Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
TearLab Corp (0001299139)
Standardized SEC financial data for TearLab Corp — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001299139 · Surgical & Medical Instruments & Apparatus.
Gross margin
63.1%
Operating margin
1.2%
Net margin
-23.9%
Revenue growth (YoY)
-9.4%
Return on equity
20.8%
ROIC
0.7%
Free cash flow
-$1.4M
Debt / equity
-2.81×
Ratios for fiscal year 2019, standardized from SEC filings.